Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_assertion type Assertion NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_head.
- NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_assertion description "[Allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for chronic myeloid leukemia and Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia, and the graft-vs-leukemia (GVL) effect can eradicate residual leukemia after allo-SCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_provenance.
- NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_assertion evidence source_evidence_literature NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_provenance.
- NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_assertion SIO_000772 22665066 NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_provenance.
- NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_assertion wasDerivedFrom befree-20150227 NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_provenance.
- NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_assertion wasGeneratedBy ECO_0000203 NP407252.RAHaLemXsFymrNmOygeZVbquT35-8utk0bT9AlHZsb_H4130_provenance.